Overall, these results suggest that alcohol use is a modifiable risk factor for AD. By focusing on AD biomarkers within the NIA-AA Research Framework, this work integrates with the broader field of age-related neurodegeneration and extends efforts to elucidate the impact of alcohol age-related neurodegeneration. Increased knowledge of specific pathologies associated with alcohol use in AD has potential to aid diagnosis and treatment.
